Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
277,487,877
-
Total 13F shares
-
109,280,872
-
Share change
-
+109,194,872
-
Total reported value
-
$2,919,429,193
-
Price per share
-
$26.72
-
Number of holders
-
115
-
Value change
-
+$2,917,131,273
-
Number of buys
-
114
Institutional Holders of Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI) as of Q2 2025
As of 30 Jun 2025,
Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
109,280,872 shares.
The largest 10 holders included
Sixth Street Partners Management Company, L.P., COATUE MANAGEMENT LLC, FMR LLC, BRAIDWELL LP, T. Rowe Price Investment Management, Inc., PRICE T ROWE ASSOCIATES INC /MD/, NEUBERGER BERMAN GROUP LLC, Silver Lake Group, L.L.C., MILLENNIUM MANAGEMENT LLC, and ORBIMED ADVISORS LLC.
This page lists
115
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.